Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lindane ban

This article was originally published in The Tan Sheet

Executive Summary

Rx head lice remedy banned in California as Gov. Gray Davis signs bill into law Sept. 5. Effective Jan. 1, 2002, the bill prohibits the sale or use of the drug to treat head lice or scabies, but permits ingredient's use as an industrial pesticide. Assemblyman Alan Lowenthal (D) and other lawmakers pushed the measure based on concerns of neurotoxicity and carcinogenicity. The journal Contemporary Pediatrics recently voiced the support of the medical community for the use of OTC head lice treatments as the first line of defense and specifically advised against the use of lindane (1"The Tan Sheet" Sept. 11, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel